This session examines how genetic, genomic, epigenetic, and molecular variations influence immune function, disease susceptibility, treatment response, and clinical outcomes. It includes immune-related gene discovery, pharmacogenomics, personalized risk assessment, molecular classification, precision diagnostics, and individualized therapeutic strategies.
Abstracts may present genomic studies, biomarker research, patient stratification, computational analyses, rare disease findings, and clinical applications of precision medicine. The session welcomes immunologists, geneticists, clinicians, bioinformaticians, molecular scientists, laboratory professionals, and industry researchers working to advance personalized approaches in immune-mediated diseases.
Title : Antibody proteases as translational biomarkers, targets, and biocatalysts of the next generation step as applicable for design driven precision medical practice
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through biodesign inspired and immunology related translational applications to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation